Tekla Life Sciences (NYSE: HQL)
You can purchase shares of Tekla Life Sciences (NYSE: HQL) through any online brokerage.
Other companies in Tekla Life Sciences’s space includes: Nuveen Real Asset I&G (NYSE:JRI), First Trust Enhanced (NYSE:FFA), Saba Capital Income (NYSE:BRW), TriplePoint Venture Gwth (NYSE:TPVG) and Columbia Seligman (NYSE:STK).
There is no analysis for Tekla Life Sciences
The stock price for Tekla Life Sciences (NYSE: HQL) is $14.72 last updated July 5, 2022, 7:58 PM UTC.
A quarterly cash dividend of $0.35 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2022 to stockholders of record on May 26, 2022.
Tekla Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Tekla Life Sciences.
Tekla Life Sciences is in the Financials sector and Capital Markets industry. They are listed on the NYSE.